These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38966504)

  • 21. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
    Assmus F; Driouich JS; Abdelnabi R; Vangeel L; Touret F; Adehin A; Chotsiri P; Cochin M; Foo CS; Jochmans D; Kim S; Luciani L; Moureau G; Park S; Pétit PR; Shum D; Wattanakul T; Weynand B; Fraisse L; Ioset JR; Mowbray CE; Owen A; Hoglund RM; Tarning J; Lamballerie X; Nougairède A; Neyts J; Sjö P; Escudié F; Scandale I; Chatelain E
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2.
    Khanna N; Pawar SV; Kumar A
    Curr Drug Res Rev; 2021; 13(3):203-221. PubMed ID: 33719950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.
    Files DC; Tacke F; O'Sullivan A; Dorr P; Ferguson WG; Powderly WG
    PLoS Pathog; 2022 Jun; 18(6):e1010547. PubMed ID: 35749425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    Front Pharmacol; 2021; 12():704205. PubMed ID: 34867318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic.
    Gajewski P; Błaziak M; Urban S; Garus M; Braunschweig F; Caldeira D; Gawor A; Greenwood JP; Guzik M; Halfwerk FR; Iwanek G; Jarocki M; Jura M; Krzystek-Korpacka M; Lewandowski Ł; Lund LH; Matysiak M; Pinto F; Sleziak J; Wietrzyk W; Sokolski M; Biegus J; Ponikowski P; Zymliński R
    Sci Rep; 2023 Oct; 13(1):17924. PubMed ID: 37864029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arts therapies for mental disorders in COVID-19 patients: a comprehensive review.
    Luo X; Zhang Z; Shi X; He C; Wang J; Wu Q; Huang G
    Front Public Health; 2023; 11():1289545. PubMed ID: 38111478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications.
    Khan S; Gionfriddo MR; Cortes-Penfield N; Thunga G; Rashid M
    Expert Opin Pharmacother; 2020 Oct; 21(15):1821-1849. PubMed ID: 32752970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current evidence for directed and supportive investigational therapies against COVID-19.
    van Rensburg R; Pillay-Fuentes Lorente V; Decloedt EH
    Afr J Thorac Crit Care Med; 2020; 26(2):. PubMed ID: 34235422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews.
    Augustin Y; Staines HM; Velavan TP; Kamarulzaman A; Kremsner PG; Krishna S
    Br Med Bull; 2023 Sep; 147(1):31-49. PubMed ID: 37312588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review.
    Roth GA; Vaduganathan M; Mensah GA
    J Am Coll Cardiol; 2022 Aug; 80(6):631-640. PubMed ID: 35926937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapies for COVID-19: An overview of the clinical trials landscape.
    Akinbolade S; Coughlan D; Fairbairn R; McConkey G; Powell H; Ogunbayo D; Craig D
    Br J Clin Pharmacol; 2022 Feb; 88(4):1590-1597. PubMed ID: 34558094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Current Clinically Relevant Findings on COVID-19 Pandemic.
    Pergolizzi JV; Magnusson P; LeQuang JA; Breve F; Paladini A; Rekatsina M; Yeam CT; Imani F; Saltelli G; Taylor R; Wollmuth C; Varrassi G
    Anesth Pain Med; 2020 Apr; 10(2):e103819. PubMed ID: 32754437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval.
    Ashour NA; Abo Elmaaty A; Sarhan AA; Elkaeed EB; Moussa AM; Erfan IA; Al-Karmalawy AA
    Drug Des Devel Ther; 2022; 16():685-715. PubMed ID: 35321497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing lipid management-impact of the COVID 19 pandemic upon cardiovascular risk in England.
    Newton JL; Hamed J; Williams H; Kearney M; Metcalfe AM; Ford GA
    Br Med Bull; 2023 Jun; 146(1):19-26. PubMed ID: 37170945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update.
    McFarthing K; Rafaloff G; Baptista M; Mursaleen L; Fuest R; Wyse RK; Stott SRW
    J Parkinsons Dis; 2022; 12(4):1073-1082. PubMed ID: 35527571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication to promote and support physical distancing for COVID-19 prevention and control.
    Ryan RE; Silke C; Parkhill A; Virgona A; Merner B; Hurley S; Walsh L; de Moel-Mandel C; Schonfeld L; Edwards AG; Kaufman J; Cooper A; Chung RKY; Solo K; Hellard M; Di Tanna GL; Pedrana A; Saich F; Hill S
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015144. PubMed ID: 37811673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient and public involvement prior to trial initiation: lessons learnt for rapid partnership in the COVID-19 era.
    Jamal Z; Perkins A; Allen C; ; Evans R; Sturgess J; Snowdon C; Clayton T; Elbourne D
    Res Involv Engagem; 2021 Mar; 7(1):13. PubMed ID: 33685526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine.
    Wüstner S; Hogger S; Gartner-Freyer D; Lebioda A; Schley K; Leverkus F
    Front Public Health; 2022; 10():804404. PubMed ID: 35252090
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.